510(k) Report

510(k) · Cleared

Cleared

DuraGen Secure Dural Regeneration Matrix

K163456510(k) SpecialCleared Jan 6, 201728-day reviewClass II21 CFR 882.5910

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Integra LifeSciences Corporation · GXQ Dura Substitute

Cleared on Jan 6, 2017 as substantially equivalent to K120600 (Integra Life Sciences, 2012) after a 28-day review. Its family tree reaches back 6 generations to 1995.

Decided
Jan 6, 2017
Review
28 days
Class
Class II
Product code
GXQ
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K950956 (1995). 9 ancestors in all, the oldest K910555 (1992). No later device cites it as a predicate yet.

  1. Root · 6 generations backK950956 Dura-Guard Dural Repair Patch, Dura-Guard Dura SubstituteBio-Vascular, Inc. · 1995
  2. 5 generations backK973706 Dura-Guard-Dural Repair PatchBio-Vascular, Inc. · 1997
  3. 4 generations backK982180 Duragen Dural Graft MatrixIntegra Lifesciences Corp. · 1999 · Recalled
  4. 3 generations backK032693 Duragen Plus Dural Graft MatrixIntegra Lifesciences Corp. · 2003 · Recalled
  5. 2 generations backK072207 Duragen XS Dural Regeneration MatrixIntegra Lifesciences Corp. · 2007 · Recalled
  6. 1 generation backK120600 Duragen Secure Dural Regneration MatrixIntegra Life Sciences · 2012
  7. This deviceK163456 DuraGen Secure Dural Regeneration MatrixIntegra LifeSciences Corporation · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K950956Dura-Guard Dural Repair Patch, Dura-Guard Dura SubstituteBio-Vascular, Inc.1995—
−5K973706Dura-Guard-Dural Repair PatchBio-Vascular, Inc.1997—
−4K982180Duragen Dural Graft MatrixIntegra Lifesciences Corp.19991
−3K032693Duragen Plus Dural Graft MatrixIntegra Lifesciences Corp.20031
−2K072207Duragen XS Dural Regeneration MatrixIntegra Lifesciences Corp.20076
−1K120600Duragen Secure Dural Regneration MatrixIntegra Life Sciences2012—
0 (this device)K163456DuraGen Secure Dural Regeneration MatrixIntegra LifeSciences Corporation2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199210
199510
199710
FIG. 1 — Lineage of K163456, 1995–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GXQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GXQ device

  1. #1 K251191 Collagen Dura Regeneration Membrane - Repairscore 12.2 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K120600Duragen Secure Dural Regneration Matrix
Summary page 5
…Manufacturer DuraGen® Secure Integra LifeSciences K120600 GXQ Dural Regeneration Corpo…
Integra Life Sciences2012—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 4 companies; a new generation was cleared every 4.2 years on median.
  • 3 of the 9 ancestors have a recall of any class.

How does its category compare?

All GXQ devices

GXQ Dura Substitute: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · GXQ

2in 2025

2007: 22010: 12012: 22013: 32014: 12015: 32016: 32017: 22019: 12022: 12023: 12025: 2
2007high 3 (2013) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GXQ

94in 2016

2013: 181 days median2015: 214 days median2016: 94 days median
2007high 214 (2015) · low 94 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GXQ

2in 2024

2010: 62013: 12021: 22024: 2
2007high 6 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GXQ

61in 2025

2007: 552008: 432009: 462010: 362011: 312012: 382013: 722014: 182015: 622016: 582017: 572018: 942019: 632020: 1142021: 762022: 592023: 1092024: 552025: 61
2007high 114 (2020) · low 18 (2014)2025

MAUDE reports naming product code GXQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—055
20080—043
20090—046
20101—636
20110—031
20122—038
20133181172
20141—018
20153214062
2016394058
20172—057
20180—094
20191—063
20200—0114
20210—276
20221—059
20231—0109
20240—255
20252—061
20260—0—

What is it indicated for?

DuraGen® Secure Dural Regeneration Matrix is indicated as a dura substitute for the repair of dura mater.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K163456: DuraGen Secure Dural Regeneration Matrix.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K163456

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026